{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T21:51:06Z","timestamp":1793224266983,"version":"4.5.0"},"reference-count":19,"publisher":"Delaware Academy of Medicine - Delaware Public Health Association","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,11]]},"DOI":"10.32481\/djph.2023.11.004","type":"journal-article","created":{"date-parts":[[2023,12,4]],"date-time":"2023-12-04T19:58:26Z","timestamp":1701719906000},"page":"12-15","source":"Crossref","is-referenced-by-count":9,"title":["CAR T Cells for Treating Severe Atopic Allergic Diseases"],"prefix":"10.32481","volume":"9","author":[{"given":"Ronald P.","family":"Dudek","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhengyu","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"13029","published-online":{"date-parts":[[2023,11,30]]},"reference":[{"key":"key20231204145823_r1","unstructured":"Raeke, M. (2023, Aug 22). The boundless potential of CAR T cell therapy, from cancer to chronic and common diseases: A Q&A with Carl June. Penn Medicine News Retrieved from https:\/\/www.pennmedicine.org\/news\/news-blog\/2023\/august\/carl-june-on-the-boundless-potential-of-car-t-cell-therapy"},{"key":"key20231204145823_r2","first-page":"S3","article-title":"An introduction to chimeric antigen receptor (CAR) T-cell immunotherapy for human cancer.","volume":"94","year":"2019","journal-title":"American Journal of Hematology"},{"issue":"1","key":"key20231204145823_r3","doi-asserted-by":"crossref","first-page":"5225","DOI":"10.1038\/s41467-022-32866-0","article-title":"Potential solutions for manufacture of CAR T cells in cancer immunotherapy.","volume":"13","year":"2022","journal-title":"Nature Communications"},{"key":"key20231204145823_r4","doi-asserted-by":"crossref","unstructured":"Schett, G., Mackensen, A., & Mougiakakos, D. (2023). CAR T-cell therapy in autoimmune diseases. Lancet. S0140-6736(23). doi: 10.1016\/S0140-6736(23)01126-1. PubMed PMID: 37748491.","DOI":"10.1016\/S0140-6736(23)01126-1"},{"issue":"3","key":"key20231204145823_r5","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1038\/nri2273","article-title":"IgE in allergy and asthma today.","volume":"8","year":"2008","journal-title":"Nature Reviews. Immunology"},{"issue":"132","key":"key20231204145823_r6","article-title":"Decade-long safety and function of retroviral-modified chimeric antigen receptor T cells.","volume":"4","year":"2012","journal-title":"Science Translational Medicine"},{"key":"key20231204145823_r7","doi-asserted-by":"crossref","unstructured":"Talay, O., Yan, D., Brightbill, H. D., Straney, E. E., Zhou, M., Ladi, E., . . . Wu, L. C. (2012, February 26). IgE+ memory B cells and plasma cells generated through a germinal-center pathway. Nature Immunology, 13(4), 396\u2013404. Epub20120301. 10.1038\/ni.225622366892","DOI":"10.1038\/ni.2256"},{"key":"key20231204145823_r8","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.3389\/fimmu.2018.02231","article-title":"chimeric antigen receptors based on low affinity mutants of FcepsilonRI re-direct T cell specificity to cells expressing membrane IgE.","volume":"9","year":"2018","journal-title":"Frontiers in Immunology"},{"key":"key20231204145823_r9","unstructured":"Chung, K. F., Wenzel, S. E., Brozek, J. L., Bush, A., Castro, M., Sterk, P. J., . . . Teague, W. G. (2014, February). International ERS\/ATS guidelines on definition, evaluation and treatment of severe asthma. The European Respiratory Journal, 43(2), 343\u2013373. Epub20131218. 10.1183\/09031936.0020201324337046"},{"issue":"3","key":"key20231204145823_r10","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1513\/AnnalsATS.201703-259OC","article-title":"The economic burden of asthma in the United States, 2008-2013.","volume":"15","year":"2018","journal-title":"Annals of the American Thoracic Society"},{"issue":"7","key":"key20231204145823_r11","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1016\/j.rmed.2006.03.031","article-title":"Uncontrolled asthma: A review of the prevalence, disease burden and options for treatment.","volume":"100","year":"2006","journal-title":"Respiratory Medicine"},{"issue":"9","key":"key20231204145823_r12","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1164\/rccm.201901-0016OC","article-title":"The projected economic and health burden of uncontrolled asthma in the United States.","volume":"200","year":"2019","journal-title":"American Journal of Respiratory and Critical Care Medicine"},{"issue":"3","key":"key20231204145823_r13","first-page":"497","article-title":"An overview of health disparities in asthma.","volume":"94","year":"2021","journal-title":"The Yale Journal of Biology and Medicine"},{"key":"key20231204145823_r14","article-title":"Monoclonal antibodies in the management of asthma: Dead ends, current status and future perspectives.","volume":"13","year":"2022","journal-title":"Frontiers in Immunology"},{"issue":"7897","key":"key20231204145823_r15","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1038\/s41586-021-04390-6","article-title":"Decade-long leukaemia remissions with persistence of CD4+ CAR T cells.","volume":"602","year":"2022","journal-title":"Nature"},{"issue":"1","key":"key20231204145823_r16","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1001\/archinte.161.1.15","article-title":"Anaphylaxis in the United States: An investigation into its epidemiology.","volume":"161","year":"2001","journal-title":"Archives of Internal Medicine"},{"issue":"7836","key":"key20231204145823_r17","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.1038\/d41586-020-02778-4","article-title":"Food allergies: The psychological toll.","volume":"588","year":"2020","journal-title":"Nature"},{"issue":"11","key":"key20231204145823_r18","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1001\/jamapediatrics.2013.2376","article-title":"The economic impact of childhood food allergy in the United States.","volume":"167","year":"2013","journal-title":"JAMA Pediatrics"},{"issue":"6","key":"key20231204145823_r19","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1111\/cea.14145","article-title":"Palforzia for peanut allergy: Panacea or predicament.","volume":"52","year":"2022","journal-title":"Clinical and Experimental Allergy"}],"container-title":["Delaware Journal of Public Health"],"original-title":[],"language":"en","deposited":{"date-parts":[[2023,12,4]],"date-time":"2023-12-04T19:58:33Z","timestamp":1701719913000},"score":1,"resource":{"primary":{"URL":"https:\/\/djph.org\/wp-content\/uploads\/2023\/12\/djph-94-004.pdf"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11]]},"references-count":19,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2023,11,30]]},"published-print":{"date-parts":[[2023,11]]}},"alternative-id":["10.32481\/djph.2023.11.004"],"URL":"https:\/\/doi.org\/10.32481\/djph.2023.11.004","relation":{},"ISSN":["2639-6378"],"issn-type":[{"value":"2639-6378","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,11]]}}}